Spots Global Cancer Trial Database for A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
Official Title: A Phase 2 Study of ARQ 501 in Patients With Locally Advanced, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Study ID: NCT00358930
Interventions
Study Description
Brief Summary: This is a Phase 2, multi-center, open label study of ARQ 501 in patients with locally advanced, recurrent or metastatic squamous cell cancer of the head and neck (SCCHN).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of South Alabama, Mobile, Alabama, United States
LA County Hospital, Los Angeles, California, United States
Norris Comprehensive Cancer Center, Los Angeles, California, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Dana-Farber, Boston, Massachusetts, United States
Washington University School of Medicine, St. Louis, Missouri, United States
New York Oncology Hematology, Albany, New York, United States
Mary Crowley Medical Research Center, Dallas, Texas, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
